BASEL, 20-Mar-2018 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMpower131 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of TECENTRIQ (atezolizumab) plus chemotherapy (carboplatin and Abraxane [albumin-bound … Read the full press release
Posted in Healthcare, Pharma & Biotech, Switzerland
Tagged atezolizumab, Cancer, chemotherapy, lung, lung cancer, lungcancer, Roche, Sandra Horning, squamous
Imfinzi is the only immunotherapy approved for patients with unresectable Stage III non-small cell lung cancer Imfinzi showed an 11.2 month improvement in median progression-free survival (16.8 months compared to 5.6 months on placebo) CAMBRIDGE, 22-Feb-2018 — /EuropaWire/ — AstraZeneca and … Read the full press release
Posted in Healthcare, Pharma & Biotech, United Kingdom
Tagged AstraZeneca, Cancer, chemotherapy, Dave Fredrickson, Imfinzi, lung, lung cancer, lungcancer, MedImmune, radiation therapy, Scott J. Antonia MD Ph.D.
GLASGOW, 05-Feb-2018 — /EuropaWire/ — A new joint venture company which brings together the University of Glasgow and Portage Pharmaceuticals is aiming to develop more effectively-targeted drugs to treat chronic conditions including cancer. Portage Pharmaceuticals, a subsidiary of the British Virgin … Read the full press release
ENSCHEDE, the Netherlands, 02-Feb-2018 — /EuropaWire/ — Detecting cancer of various types, in a very early stage and using a simple urine sample. That is the ambition of the new startup company NanoMed Diagnostics. Years of research, by scientists of the … Read the full press release
LONDON, 01-Dec-2017 — /EuropaWire/ — On December 5-6, 2017, 200 high-level experts from government, academia, biopharmaceutical developers and patient organisations convene in London (UK) to address the mounting challenge of accessibility and patient access to high-value, high-cost medical therapies. The … Read the full press release
Posted in Government, Healthcare, News, Non Profit, Pharma & Biotech, Science, Society, United Kingdom
Tagged academia, Aetna, analytica|LASER, auto-immune diseases, biopharmaceutical, biopharmaceutical developers, Cancer, deadly HIV epidemic, Dr. Harold Paz, Dr. Olivier Brandicourt, Dr. Sarah Garner, drug developers, drug policy, EURORDIS-Rare Diseases Europe, French HAS, global health systems sustainability, government, health ministries, health systems, Healthcare, high-cost medical therapies, high-value medicines, Julia Corner, life-saving drugs, London School of Hygiene and Tropical Medicine, medicine access, medicine accessibility, National Institute for Health and Care Excellence, not-for-profit event, patient access, patient organisations, Pharmaceutical, Prof Peter Piot, Prof. Dominique Le Guludec, Prof. Lucien Abenhaim, rare disease, rare diseases, Renaissance St Pancras Hotel, Sanofi, Sir Andrew Dillon, Ulrich Neumann, World Health Organization, Yann Le Cam
Holzkirchen, Germany, 18-Feb-2016 — /EuropaWire/ — Sandoz, together with leading global charity World Child Cancer (WCC), is pleased to announce a new health initiative in the Philippines, aimed at improving the standard of care for children suffering from cancer. Cancer survival … Read the full press release
Posted in Germany, Healthcare, Society
Tagged Cancer, health initiative in the Philippines, Jon Rosser, Paul Geymayer, Sandoz, World Child Cancer
COVENTRY, 11-6-2015 — /EuropaWire/ — Staff, family and friends of the University of Warwick will on Sunday 14th June raise funds for ground-breaking research by taking part in the Two Castles Run. The Two Castles Run see runners make their … Read the full press release
Posted in Education, Healthcare, Management, Marketing, Science, Society, Sports, Technology
Tagged Cancer, dementia, Jaine Fleetwood, miscarriage, Natasha Lynch, research into premature birth, The Grace Research Fund, Two Castles Run, University Hospitals Coventry, University of Warwick, Warwickshire (UHCW) NHS Trust
The University of Aberdeen has secured a grant of up to £1.5million from Cancer Research UK to study how tumours develop. ABERDEEN, 18-3-2015 — /EuropaWire/ — The grant will fund a five-year programme of research led by Professor Anne Donaldson … Read the full press release
A new branch of mathematics has been established to create a better drug control system to cure cancer. Bristol, UK, 6-2-2014 — /EuropaWire/ — Scientists, including Professor Tanniemola Liverpool from the University of Bristol’s School of Mathematics, claim that by understanding how an artificial ‘synthetic … Read the full press release
Researchers from Faculty of Health and Medical Sciences, University of Copenhagen, have characterized a genetic aberration on a group of colorectal cancer patients. The discovery gives hope for a new and efficient treatment of colorectal cancer, which is a frequent … Read the full press release
London, United Kingdom, 10-10-2013 — /EuropaWire/ — AstraZeneca today announced that on 4 October MedImmune, its global biologics research and development arm, completed its acquisition of Amplimmune, a privately-held, US-based biologics company focused on developing novel therapeutics in cancer immunology. As previously announced, … Read the full press release
Posted in Business, Financial, Healthcare, Investment, Pharma & Biotech, United Kingdom
Tagged acquisition, Amplimmune, Anthony Brown, anti-PD-L1 mAb, AstraZeneca, autoimmune disease, Ayesha Bharmal, biologics, Cancer, cancer cells, cancer immunology, co-inhibitory molecules, co-stimulatory molecules, Colleen Proctor, Ed Seage, Esra Erkal-Paler, Gaithersburg, immune system, immune-mediated cancer therapy, IMT-C, infectious disease, Jacob Lund, Jens Lindberg, Karl Hård, MEDI-4736, MedImmune, mOX40 mAb, therapeutics, Tracy Rossin, transplantation, tremelimumab
New test expands cancer diagnostics portfolio and strengthens Roche Diagnostics’ comprehensive tumour marker menu 19-7-2013 — /europawire.eu/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global launch (except US) of Elecsys ProGRP, a test that distinguishes between the two … Read the full press release
Posted in Business, Healthcare, Pharma & Biotech, Science, Switzerland
Tagged Cancer, cancer diagnosis, lung cancer, non-small cell, NSCLC, ProGRP test, Roche, SCLC, small cell
16-7-2013 — /europawire.eu/ — AstraZeneca today announced that it has entered into an agreement with the University of Cambridge and Cancer Research UK for a two-year collaboration on three pre-clinical and clinical oncology projects. This agreement with world-leading medical research institutions … Read the full press release
Posted in Business, Education, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged AstraZeneca, Babraham Institute, Cambridge University Hospitals, Cancer, cancer research, Cancer Research UK, cancers, collaboration, David Neal, medical research, Olaparib, oncology, oncology projects, pancreatic, prostate, selumetinib, Susan Galbraith, tumour mutations, University of Cambridge
4-6-2013 — /europawire.eu/ — Scientists at the University of Leeds have found a way to target and destroy a key protein associated with the development of cervical and other cancers. The E7 protein is produced early in the lifecycle of the … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged Aptamers, BBSRC, Cancer, carcinogenic protein, cervical cancer, Dr Nicola Stonehouse, E7 protein, HPV, HPV positive, human papillomavirus, molecule, papillomavirus, RNA aptamer, RNA aptamers, scientists, University of Leeds, virus infection, Yorkshire Cancer Research
University of Leicester Professor in study for early detection of disease 7-5-2013 — /europawire.eu/ — National charity Pancreatic Cancer UK has today announced the award of a £72,000 grant to Professor Jacqui Shaw and colleagues at the University of Leicester as … Read the full press release
Posted in Education, Financial, Healthcare, Non Profit, Science, Society, United Kingdom
Tagged Cancer, cancer research, charity, Dr Martins, Dr Neal, grant, grants, Jacqui Shaw, lethal disease, pancreatic cancer, pancreatic cancer research, Pancreatic Cancer UK, Professor Manson, UK, University of Leicester
Noel Gallagher’s handpicked musical line up promises to thrill at Royal Albert Hall charity gigs 12-3-2013 — /europawire.eu/ — This March the Teenage Cancer Trust returns to the Royal Albert Hall. The charity, whose long standing relationship with the music sphere … Read the full press release
Posted in Art & Culture, Entertainment, Healthcare, News, Non Profit, Society, Travel, United Kingdom
Tagged Cancer, charity, Healthcare, leukaemia, Noel Gallagher, Non Profit, Royal Albert Hall, Teenage Cancer Trust, teenagers
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
